Keyphrases
Finland
100%
Epidemiology
100%
Poland
100%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
100%
PCV10
100%
Pneumococcal Meningitis
100%
Fatality
25%
Bacterial Meningitis
25%
Incidence Rate
18%
Meningitis
18%
S. Pneumoniae
18%
European Countries
12%
Conjugate Vaccine
12%
Pneumococcus
12%
Substantial Reduction
6%
Age Groups
6%
Most Common Cause
6%
Older Adults
6%
Mortality Rate
6%
Surveillance Data
6%
Disease Burden
6%
Annual Incidence
6%
Severe Infection
6%
Population-based
6%
Overall Mortality
6%
Long-term Trends
6%
Surveillance System
6%
Sepsis
6%
Streptococcus Pneumoniae
6%
Age-specific Incidence
6%
Pneumococcal Conjugate Vaccine
6%
Penicillin
6%
Vaccine Introduction
6%
Serotype Distribution
6%
National Population
6%
National Immunization Program
6%
Antimicrobial Susceptibility
6%
Pneumonia
6%
January 2017
6%
Baseline Period
6%
Cefepime
6%
Total Burden
6%
National Surveillance Data
6%
Population-based Surveillance
6%
Decreased Susceptibility
6%
Medicine and Dentistry
Pneumococcal Meningitis
100%
Cohort Effect
100%
Pneumococcus Vaccine
100%
Serotype
83%
Bacterial Meningitis
33%
Case Fatality Rate
33%
Meningitis
25%
Pneumococcus
25%
Streptococcus Pneumonia
25%
Conjugate Vaccine
16%
Disease Burden
8%
Infection
8%
Mortality Rate
8%
Sepsis
8%
Surveillance System
8%
Antibiogram
8%
Cefotaxime
8%
Pneumococcal Pneumonia
8%
Penicillin
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pneumococcal Meningitis
100%
Pneumococcus Vaccine
100%
Bacterial Meningitis
33%
Case Fatality Rate
33%
Meningitis
25%
Streptococcus Pneumonia
25%
Conjugate Vaccine
16%
Mortality Rate
8%
Infection
8%
Antiinfective Agent
8%
Sepsis
8%
Cefotaxime
8%
Diseases
8%
Penicillin
8%
Immunology and Microbiology
Pneumococcal Vaccine
100%
Meningitis
100%
Serotype
52%
Case Fatality Rate
21%
Pneumococcus
15%
Streptococcus Pneumonia
15%
Conjugate Vaccine
10%
Mortality Rate
5%
Penicillin
5%
Disease Burden
5%
Antibiotic Sensitivity
5%